Osmol Therapeutics: Funding, Investors & Team (Sep 2026)
Osmol Therapeutics develops treatment to prevent chemotherapy-induced peripheral neuropathy. The company was founded in 2016 and is headquartered in New Haven, Connecticut, United States.
Osmol Therapeutics has raised $5.2M across 1 funding round on record, the most recent a Series A of $5.2M announced in Apr 2022.
That round is above the $4.7M median round size for Health Care companies tracked on FundedIQ over the last two years.
Osmol Therapeutics Company Profile and Key Stats
Latest funding round on record: Apr 2022.
Osmol Therapeutics Funding Rounds
Osmol Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Osmol Therapeutics Funding Compared to Other Health Care Startups
Osmol Therapeutics' latest round of $5.2M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Osmol Therapeutics in Health Care and New Haven
Companies Similar to Osmol Therapeutics
https://metriport.com
There are too many reasons why Healthcare is unaffordable in the U.S, but one of the largest is waste. Up to…
Serif Health provides healthcare price intelligence and contract management solution.
Switchboard Health provides virtual care solutions to payers, health systems, employers, and at-risk…
Astek Diagnostics has designed a system that helps doctors choose the right antibiotics for patients…
TECLens is developing a crosslinking technology that can effectively address vision problems in both healthy…
Healthcare Shares operates as a crowdfunding portal for the transformative medical innovations of the future.
Gradient Health collaborates with medical data providers worldwide to assemble diseases and conditions for AI…
Kalivir designs safe and potent oncolytic product candidates across multiple tumor types. Kalivir’s…
Happy Health is a mission-driven technology company committed to transforming mental health awareness through…
Leal Therapeutics creates new treatments for patients.
Teal Health is on a mission to empower women when it comes to their health – starting with at-home cervical…
Osmol Therapeutics Funding FAQs
What does Osmol Therapeutics do?
Osmol Therapeutics develops treatment to prevent chemotherapy-induced peripheral neuropathy. The company was founded in 2016 and is headquartered in New Haven, Connecticut, United States.
How much funding has Osmol Therapeutics raised?
Osmol Therapeutics has raised $5.2M across 1 round on record. The most recent is a Series A of $5.2M announced in Apr 2022.
When did Osmol Therapeutics last raise funding?
Osmol Therapeutics' most recent funding round on record is a Series A of $5.2M, announced in Apr 2022.
Who is the CEO of Osmol Therapeutics?
Bob Linke is listed as CEO at Osmol Therapeutics.
Where is Osmol Therapeutics headquartered?
Osmol Therapeutics is based in New Haven, Connecticut, United States.
How many employees does Osmol Therapeutics have?
Osmol Therapeutics is in the 1-10 employee band.
How does Osmol Therapeutics' funding compare to other Health Care startups?
Osmol Therapeutics' latest round of $5.2M is above the $4.7M median round size for Health Care companies on FundedIQ across 3,653 tracked companies over the last two years.
About FundedIQ's Osmol Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Osmol Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.